Global Hemorrhoids Treatment Market
Market Size in USD Billion
CAGR :
% 
USD
914.00 Billion
USD
2.24 Billion
2024
2032
 Forecast Period |
2025 –2032 |
 Market Size (Base Year) |
USD 914.00 Billion |
 Market Size (Forecast Year) |
USD 2.24 Billion |
 CAGR |
% |
| Major Markets Players |
|
Global Haemorrhoids Treatment Market Segmentation, By Type (Internal Haemorrhoids and External Haemorrhoids), Treatment (Medication, Devices, and Surgery), Drugs (Topical Steroids, Topical Anaesthetics, and Others), Devices (Cryotherapy Devices, Haemorrhoid Laser Probes, and Others), Route of Administration (Oral, Topical, and Others), End Users (Hospitals, Homecare, Specialty Clinics, and Others) - Industry Trends and Forecast to 2032
Haemorrhoids Treatment Market Size
- The global haemorrhoids treatment market was valued at USD 914.0 million in 2024 and is expected to reach USD 2.24 billion by 2032
- During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 11.88%, primarily driven by the increasing prevalence of hemorrhoidal conditions
- This growth is driven by factors such as the rising awareness and access to treatment, and advancements in treatment options
Haemorrhoids Treatment Market Analysis
- Haemorrhoid treatments are essential for managing a common condition affecting individuals worldwide, involving swelling and inflammation of veins in the rectum and anus. The treatment methods range from conservative approaches, such as lifestyle changes and topical creams, to more advanced procedures such as minimally invasive surgeries and, in severe cases, surgical interventions
- The demand for haemorrhoid treatments is significantly driven by factors such as an increasing global prevalence of hemorrhoidal conditions, particularly due to rising rates of constipation, obesity, sedentary lifestyles, and aging populations. Lifestyle changes and dietary habits, including low fiber intake, have further contributed to the growing incidence of haemorrhoids
- North America is the dominant region for the haemorrhoid treatment market, driven by a high awareness of treatment options, advanced healthcare infrastructure, and a large number of healthcare facilities. The increasing aging population in countries such as the U.S. contributes to a steady rise in cases, making effective treatments more necessary. Moreover, technological advancements, such as minimally invasive procedures, have positively impacted the market in this region
- For instance, the demand for non-surgical treatments such as rubber band ligation, laser treatments, and radiofrequency ablation is on the rise in North America, thanks to quicker recovery times, fewer complications, and better patient outcomes
- Globally, non-invasive treatments, such as over-the-counter medications, topical creams, and minimally invasive procedures such as band ligation and sclerotherapy, hold a significant share in the hemorrhoid treatment market. These treatments are popular for their effectiveness, reduced recovery times, and minimal side effects, making them essential for improving the quality of life for affected individuals
- Asia-Pacific is expected to witness the highest growth rate in the haemorrhoid treatment market, driven by increased healthcare awareness, an expanding middle class, and rising disposable incomes in countries such as India and China. In addition, the rapid development of healthcare infrastructure and the increasing adoption of modern treatment options are driving market expansion in this region
Report Scope and Haemorrhoids Treatment Market Segmentation
|
Attributes |
Haemorrhoids Treatment Market Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
North America
Europe
Asia-Pacific
Middle East and Africa
South America
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework. |
Hemorrhoids Treatment Market Trends
“Increasing Adoption of Minimally Invasive Procedures”
- One prominent trend in the global haemorrhoids treatment market is the growing shift toward minimally invasive procedures
- These procedures, such as rubber band ligation, laser therapy, and infrared coagulation, offer patients quicker recovery times, reduced pain, and fewer complications compared to traditional surgical methods
- For instance, laser therapy, which uses focused light to remove or shrink hemorrhoidal tissue, is becoming increasingly popular due to its precision and effectiveness in treating both internal and external hemorrhoids
- The rising preference for these techniques is driving demand for innovative treatment devices, making minimally invasive procedures a key focus for market players aiming to enhance patient experience and outcomes
Haemorrhoids Treatment Market Dynamics
Driver
“Rising Prevalence of Hemorrhoids and Lifestyle Changes”
- The increasing prevalence of haemorrhoids, driven by factors such as sedentary lifestyles, poor dietary habits, and obesity, is significantly fuelling the demand for effective treatments. Haemorrhoids, commonly caused by excessive straining during bowel movements, are becoming more prevalent with modern lifestyles that include low fiber diets and extended periods of sitting
- With aging populations and rising cases of obesity, the frequency of haemorrhoid occurrences is growing, leading to an increased need for medical interventions such as minimally invasive treatments and surgical options
- In addition, advancements in surgical techniques and treatment devices, including laser therapy, rubber band ligation, and infrared coagulation, offer patients safer and more effective solutions
For instance,
- In January 2023, the International Journal of Colorectal Disease reported that more than 50% of adult’s worldwide experience haemorrhoids at some point in their life, driving the demand for diverse treatment options
- According to the American Society of Colon and Rectal Surgeons (ASCRS), over 10 million Americans are affected by haemorrhoids annually, underscoring the widespread need for haemorrhoid treatments globally
- The rising global prevalence of haemorrhoids, driven by lifestyle and demographic factors, is significantly boosting the demand for advanced and diverse treatment options
Opportunity
“Advancements in Minimally Invasive Treatments”
- The adoption of minimally invasive treatment options for hemorrhoids, such as laser therapy, rubber band ligation, and cryotherapy, is transforming the market by offering patients reduced pain, faster recovery, and fewer complications compared to traditional surgeries
- These non-surgical treatment options are particularly popular due to their quicker recovery times and lower risk of infection, which is appealing to both healthcare providers and patients
- In addition, innovations such as home-based treatment devices and over-the-counter medication provide patients with greater convenience and privacy in managing their condition
For instance,
- In February 2024, according to a report by the National Institute of Health, laser therapy for hemorrhoids treatment has seen increased adoption due to its precision, minimal invasiveness, and reduced downtime for patients
- In December 2023, a new cryotherapy device designed for home use was introduced, allowing patients to manage their hemorrhoids more effectively from the comfort of their homes, contributing to market growth
- The growing adoption of minimally invasive treatments and home-based solutions is revolutionizing hemorrhoids care by enhancing patient comfort, recovery, and convenience
Restraint/Challenge
“Lack of Awareness and Misconceptions”
- Despite the growing prevalence of hemorrhoids, a significant portion of the population remains unaware of effective treatment options, often leading to late-stage diagnoses and suboptimal outcomes
- Many individuals hesitate to seek professional medical care due to the stigma surrounding hemorrhoids, often opting for over-the-counter remedies that may not address the underlying issue
- This lack of awareness and the stigma surrounding the condition limit the adoption of advanced treatment methods and create challenges in ensuring timely intervention
For instance,
- A 2022 study published in the Journal of Colorectal Disease revealed that a significant number of people with hemorrhoids fail to seek medical advice, with many relying on self-treatment methods such as topical creams and lifestyle changes
- The challenge of educating the population about hemorrhoid treatment options and reducing the stigma associated with the condition is a key factor hindering market growth
Haemorrhoids Treatment Market Scope
The market is segmented on the basis of type, treatment, drugs, devices, route of administration and end user
|
Segmentation |
Sub-Segmentation |
|
By Type |
|
|
By Treatment |
|
|
By Drugs |
|
|
By Devices
|
|
|
By Routes of administration |
|
|
By End User
|
|
Haemorrhoids Treatment Market Regional Analysis
“North America is the Dominant Region in the Haemorrhoids Treatment Market”
- North America leads the global haemorrhoids treatment market, supported by advanced healthcare infrastructure, high adoption of innovative medical treatments, and the presence of major healthcare providers
- U.S. holds a significant share, driven by a growing demand for minimally invasive treatment options, rising awareness about hemorrhoidal conditions, and the increased prevalence of lifestyle-related diseases such as obesity, which often contribute to haemorrhoids
The availability of robust healthcare insurance coverage and strong research & development investments from key pharmaceutical companies further bolsters market growth in the region - In addition, the increasing preference for non-surgical treatment options, such as laser therapy, rubber band ligation, and cryotherapy, is fuelling market expansion in North America
“Asia-Pacific is Projected to Register the Highest Growth Rate”
- Asia-Pacific is anticipated to experience the highest growth rate in the haemorrhoids treatment market, driven by rapid improvements in healthcare infrastructure, a growing aging population, and increasing awareness of gastrointestinal health
- Countries such as China, India, and Japan are becoming key markets, with rising cases of haemorrhoids due to lifestyle changes, increased urbanization, and dietary shifts
- Japan, with its advanced medical technologies and increasing healthcare expenditure, is expected to remain a critical market for both traditional and minimally invasive haemorrhoid treatments
- China and India are witnessing significant growth in the demand for modern haemorrhoids treatments, fuelled by rising healthcare investments and the increasing accessibility of treatment options across urban and rural areas. These developments are expected to support market growth and improve treatment access for a large population segment
Haemorrhoids Treatment Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
The Major Market Leaders Operating in the Market Are:
- Pfizer Inc. (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- GSK plc (U.S.)
- F. Hoffmann-La Roche Ltd (U.S.)
- Novartis AG (Switzerland)
- AstraZeneca (U.K.)
- Lilly (U.S.)
- Abbott (U.S.)
- Merck & Co., Inc. (U.S.)
- AbbVie Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Takeda Pharmaceutical Company Limited (Japan)
- Bristol-Myers Squibb Company (U.S.)
- Medtronic (U.S.)
- Bayer AG (Germany)
- Olympus Corporation (Japan)
- Lupin (India)
- Boehringer Ingelheim International GmbH (Germany)
Latest Developments in Global Haemorrhoids Treatment Market
- In January 2025, Medtronic announced the launch of its Minimally Invasive Hemorrhoid Treatment System in the European Union after receiving CE Mark approval. This advanced system features a cutting-edge radiofrequency technology designed to offer reduced discomfort and faster recovery times compared to traditional hemorrhoidectomy procedures. The treatment also minimizes the risk of complications and enhances patient satisfaction by offering a less invasive alternative for hemorrhoids treatment
- In December 2024, Ferguson Healthcare introduced the ThermoTherm Hemorrhoid Treatment System at the American Society of Colon and Rectal Surgeons (ASCRS) Annual Meeting. The new system uses targeted heat therapy to shrink hemorrhoidal tissue while promoting faster healing. It is designed to be performed in outpatient settings, allowing patients to return to their daily activities with minimal downtime
- In November 2024, C.R. Bard (a leading manufacturer of medical devices) presented its Laser Hemorrhoidoplasty System at the International Hemorrhoid Surgery Conference. This innovative system uses laser energy to shrink hemorrhoidal tissue effectively, reducing the need for traditional surgery and lowering the risk of recurrence. The system is ideal for patients looking for a minimally invasive solution with less postoperative pain and quicker recovery times
- In October 2024, Smith & Nephew launched its EndoThermal Hemorrhoids Treatment Kit in North America. This innovative device utilizes a thermocoagulation technique to treat grade II and III hemorrhoids, offering patients a highly effective, quick, and minimally invasive option. The launch is set to expand the company’s portfolio in the hemorrhoid treatment market, as it aims to increase patient access to advanced treatment options
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
Frequently Asked Questions
What is the current market size of the global haemorrhoids treatment market?
The global haemorrhoids treatment Market size was valued at USD 914.0 million in 2024.
What is the expected growth rate of global haemorrhoids treatment market?
The global haemorrhoids treatment market is to grow at a CAGR of 11.88% during the forecast period of 2025 to 2032.
What are the primary segments covered in the global haemorrhoids treatment market report?
The haemorrhoids treatment market is segmented into six notable segments based on type, treatment, drugs, devices, route of administration and end user. On the basis of type, the market is segmented into internal haemorrhoids and external haemorrhoids. On the basis of treatment, the market is segmented into medication, devices, and surgery. On the basis of drugs, the market is segemntsd into topical steroids, topical anaesthetics, and others. On the basis of devices, the market is segmented into cryotherapy devices, haemorrhoid laser probes, and others. On the basis of route of administration, the market is segmented into oral, topical, and others. On the basis of end user, the market is segmented into hospitals, homecare, specialty clinics, and others.
Who are major players in global haemorrhoids treatment market?
Companies such Pfizer Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), GSK plc (U.S.), F. Hoffmann-La Roche Ltd (U.S.) and Novartis AG (Switzerland) are the major companies in the haemorrhoids treatment market.
What are the recent product launches by major companies in the global haemorrhoids treatment market?
In recent developments in haemorrhoid treatment, Medtronic launched its Minimally Invasive Haemorrhoid Treatment System in January 2025 in the European Union, utilizing advanced radiofrequency technology to offer reduced discomfort and quicker recovery. Similarly, in December 2024, Ferguson Healthcare introduced the ThermoTherm Haemorrhoid Treatment System at the ASCRS Annual Meeting, which uses targeted heat therapy to shrink hemorrhoidal tissue, providing a fast-healing, outpatient solution with minimal downtime for patients
Which countries data is covered in the global haemorrhoids treatment market?
The countries covered in the global haemorrhoids treatment market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, and rest of Middle East and Africa.
What are the key trends in the the global haemorrhoids treatment market?
The increasing adoption of minimally invasive procedures is emerging as a pivotal trend driving the global haemorrhoids treatment market.
Which is the dominating segment in the global haemorrhoids treatment market??
The internal haemorrhoids segment is expected to dominate global haemorrhoids treatment holding a major market share in 2025, due to its higher prevalence and demand for medical interventions.
Which is the fastest growing region in the global haemorrhoids treatment market?
Asia-Pacific is the fastest growing region in the global haemorrhoids treatment market due to rising awareness in healthcare.
What are the factors driving the haemorrhoids treatment Market growth?
The major factors driving the growth of the global haemorrhoids treatment market are rising prevalence of haemorrhoids and lifestyle changes.
What are the major challenges in the global haemorrhoids treatment market??
The primary challenges include lack of awareness and misconceptions, high equipment costs hindering market penetration and competitive market dynamics challenging brand differentiation.
Which country is expected to dominate in the global haemorrhoids treatment market?
U.S. is expected to dominate the global haemorrhoids treatment market, particularly in the North America region. This dominance is attributed because of its advanced healthcare infrastructure.
Which region has the largest share in the global haemorrhoids treatment market??
North America is expected to dominate the the global haemorrhoids treatment market due to advanced healthcare infrastructure.
Which country is expected to witness the highest CAGR in the the global haemorrhoids treatment market?
India is expected to witness the highest CAGR in the global haemorrhoids treatment market. This growth is driven by increased healthcare spending and a large population.
